PMID- 17480175 OWN - NLM STAT- MEDLINE DCOM- 20070517 LR - 20191110 IS - 1744-764X (Electronic) IS - 1474-0338 (Linking) VI - 6 IP - 3 DP - 2007 May TI - The adverse effects of antiepileptic drugs in children. PG - 251-65 AB - Efficacy of antiepileptic drugs (AEDs) are often equivalent, hence selection of an AED is often determined by the adverse effects (AEs). The development of neurocognitive AEs is almost inevitable with use of AEDs, especially in high-risk groups. Teratogenesis with major or minor malformations is of great concern during the first trimester of pregnancy, but an increasing body of information suggests that potential neurocognitive developmental delay may also occur with use of AEDs in the latter part of pregnancy. Decreased bone mineral density has been found in adults and children receiving both enzyme-inducing AEDs and valproate, an enzyme-inhibiting drug. AEDs may influence the lipid profile, body weight, reproductive, hormonal and other endocrine functions, and sleep architecture. There are age-specific AEs related to pharmacokinetic differences that have been highlighted in this review with emphasis on the pediatric population. A classification of AEs using different parameters is also included. FAU - Kothare, Sanjeev V AU - Kothare SV AD - St Christopher's Hospital for Children, Section of Neurology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19134, USA. skothare@drexelmed.edu FAU - Kaleyias, Joseph AU - Kaleyias J LA - eng PT - Journal Article PT - Review PL - England TA - Expert Opin Drug Saf JT - Expert opinion on drug safety JID - 101163027 RN - 0 (Anticonvulsants) RN - 0 (Lipids) SB - IM MH - Abnormalities, Drug-Induced/etiology MH - Anticonvulsants/*adverse effects MH - Blood Cells/drug effects MH - Body Weight/drug effects MH - Bone Density/drug effects MH - Child MH - Cognition/drug effects MH - Female MH - Fetus/drug effects MH - Humans MH - Lipids/blood MH - Pregnancy MH - Reproduction/drug effects MH - Sleep/drug effects RF - 133 EDAT- 2007/05/08 09:00 MHDA- 2007/05/18 09:00 CRDT- 2007/05/08 09:00 PHST- 2007/05/08 09:00 [pubmed] PHST- 2007/05/18 09:00 [medline] PHST- 2007/05/08 09:00 [entrez] AID - 10.1517/14740338.6.3.251 [doi] PST - ppublish SO - Expert Opin Drug Saf. 2007 May;6(3):251-65. doi: 10.1517/14740338.6.3.251.